focus -WSS

focus

author：hotspot 2025-09-03 07:36:19 - browse：934

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： FDA's Woodcock to retire early next year

hotspot

WSS

CDC picks Alphabet's Verily for wasterwater surveillance contract

Wegovy, Zepbound and weight loss drugs that preserve muscle

Surge of respiratory disease in China has likely explanation

A daunting task: navigating dual Medicare, Medicaid eligibility

The biotech scorecard for Q4: 16 stock

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

knowledge

focus

explore

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

How one medical school became remarkably diverse

The biotech scorecard for Q4: 16 stock

Dobbs anniversary: the lost opportunity of abortion as health care

Weight loss drug costs may need more research, senator suggests

Drug repurposing or repositioning? The language matters

Surge of respiratory disease in China has likely explanation

Drug repurposing or repositioning? The language matters

Setback for rare diseases as Taysha Gene Therapies pulls back

knowledge

Why medical students are struggling with mental health

Astellas still sees hope in its gene therapy after four deaths

Childhood cancer progress stalls for Black, Hispanic kids: Report

Wegovy, Zepbound and weight loss drugs that preserve muscle

Anthos stroke drug appears safer than common blood thinner

Will an HIV vaccine ever be a reality?

entertainment

hotspot

hotspot

Wikipedia